Bipartisan lawmakers urge the FDA to close a loophole used to import knockoff retatrutide
Members of both parties want the FDA to shut the import route bringing in copies of Eli Lilly's retatrutide, an obesity drug that is still investigational.
Recap by typeshit. Full story at STAT.